Evaluation of endothelial dysfunction in hypothyroid neonates that referred to Endocrine & Metabolic Research Center of Isfahan

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT138812153493N1

Enrollment

Registered

2010-05-25

Start date

2009-01-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endothelial dysfunction in neonate with hypothyroidism.

Interventions

Tablet Levothyroxin 10 micrograms per kg per day.

Treatment - Drugs

Tablet Levothyroxin 10 micrograms per kg per day

Eligibility

Sex/Gender

All

Age

No minimum to 1 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 2 weeks, Exclusion criteria: Presence of any proven disease, receiving any drug, Small for gestational age infants, presence of Septicemia, presence of inherited metabolic diseases

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Von-Willbrand factor. Timepoint: before and 4 weeks after treatment with Levothyroxin. Method of measurement: ELISA.;ICAM. Timepoint: before and 4 weeks after treatment with Levothyroxin. Method of measurement: ELISA.;VICAM. Timepoint: before and 4 weeks after treatment with Levothyroxin. Method of measurement: ELISA.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mahin Hashemipour

Isfahan University of Medical Sciences

hashemipour@med.mui.ac.ir+98 31 1668 5555

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026